Assignee
NOGRA PHARMA LTD
IE·44 granted patents·29 pending applications·400 citations·filing 2013–2024
Top patents by PatentIndex Score
73 records- 0198US10398667B2Methods of treating hair related conditionsNOGRA PHARMA LTD·Filed 2018·Granted Sep 3, 2019·8 cites·16 claims
- 0298US9901557B2Methods of treating hair related conditionsNOGRA PHARMA LTD·Filed 2015·Granted Feb 27, 2018·9 cites·26 claims
- 0398US9511041B2Alkylamido compounds and uses thereofNOGRA PHARMA LTD·Filed 2014·Granted Dec 6, 2016·14 cites·8 claims
- 0498US8648186B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2013·Granted Feb 11, 2014·45 cites·6 claims
- 0597US9605264B2Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2016·Granted Mar 28, 2017·13 cites·7 claims
- 0697US9518264B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2016·Granted Dec 13, 2016·13 cites·3 claims
- 0797US9382541B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2015·Granted Jul 5, 2016·15 cites·10 claims
- 0897US9279126B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2015·Granted Mar 8, 2016·16 cites·10 claims
- 0997US9096854B1Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2015·Granted Aug 4, 2015·19 cites·6 claims
- 1096US10137101B2Alkylamido compounds and uses thereofNOGRA PHARMA LTD·Filed 2016·Granted Nov 27, 2018·8 cites·6 claims
- 1196US9682923B2Methods of treating fibrosisNOGRA PHARMA LTD·Filed 2013·Granted Jun 20, 2017·15 cites·4 claims
- 1296US9006418B2Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2013·Granted Apr 14, 2015·19 cites·11 claims
- 1396US8907078B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2014·Granted Dec 9, 2014·20 cites·10 claims
- 1495US10959970B2Methods of treating hair related conditionsNOGRA PHARMA LTD·Filed 2019·Granted Mar 30, 2021·5 cites·15 claims
- 1595US9951334B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2017·Granted Apr 24, 2018·8 cites·3 claims
- 1695US9345680B2Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical fieldNOGRA PHARMA LTD·Filed 2015·Granted May 24, 2016·15 cites·10 claims
- 1794US11753365B2Methods of treating fibrosisNOGRA PHARMA LTD·Filed 2021·Granted Sep 12, 2023·2 cites·8 claims
- 1894US10036022B2Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2016·Granted Jul 31, 2018·7 cites·6 claims
- 1994US9499819B2Antisense compositions and methods of making and using sameNOGRA PHARMA LTD·Filed 2014·Granted Nov 22, 2016·14 cites·28 claims
- 2094US9314434B2Antisense compositions and methods of making and using sameNOGRA PHARMA LTD·Filed 2014·Granted Apr 19, 2016·17 cites·9 claims
- 2194US9133099B2Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical fieldNOGRA PHARMA LTD·Filed 2014·Granted Sep 15, 2015·17 cites·3 claims
- 2293US12291494B2Methods of treating fibrosisNOGRA PHARMA LTD·Filed 2023·Granted May 6, 2025·1 cites·9 claims
- 2393US11046641B2Methods of treating fibrosisNOGRA PHARMA LTD·Filed 2017·Granted Jun 29, 2021·4 cites·8 claims
- 2493US9561202B2Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical fieldNOGRA PHARMA LTD·Filed 2015·Granted Feb 7, 2017·11 cites·9 claims
- 2592US9982264B2Antisense compositions and methods of making and using sameNOGRA PHARMA LTD·Filed 2016·Granted May 29, 2018·8 cites·19 claims
- 2691US10016381B2Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical fieldNOGRA PHARMA LTD·Filed 2016·Granted Jul 10, 2018·7 cites·12 claims
- 2790US12012418B2Aryl receptor modulators and methods of making and using the sameNOGRA PHARMA LTD·Filed 2022·Granted Jun 18, 2024·1 cites·3 claims
- 2890US10473669B2Methods for treating inflammatory bowel diseaseNOGRA PHARMA LTD·Filed 2015·Granted Nov 12, 2019·4 cites·26 claims
- 2990US10006029B2Methods of treating colorectal cancerNOGRA PHARMA LTD·Filed 2014·Granted Jun 26, 2018·7 cites·13 claims
- 3090US9913817B2Methods for preventing or reducing colon carcinogenesisNOGRA PHARMA LTD·Filed 2016·Granted Mar 13, 2018·8 cites·2 claims
- 3189US10738309B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2018·Granted Aug 11, 2020·1 cites·3 claims
- 3289US10633660B2Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical fieldNOGRA PHARMA LTD·Filed 2018·Granted Apr 28, 2020·1 cites·7 claims
- 3389US10272047B2Antisense compositions and methods of making and using sameNOGRA PHARMA LTD·Filed 2016·Granted Apr 30, 2019·5 cites·23 claims
- 3489US9682050B2Methods of treating lactose intoleranceNOGRA PHARMA LTD·Filed 2013·Granted Jun 20, 2017·12 cites·9 claims
- 3588US10337004B2Methods and compositions for treating a subject with a SMAD7 antisense oligonucleotideNOGRA PHARMA LTD·Filed 2015·Granted Jul 2, 2019·6 cites·8 claims
- 3687US10081809B2Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantationNOGRA PHARMA LTD·Filed 2013·Granted Sep 25, 2018·10 cites·26 claims
- 3786US12577256B2Aryl receptor modulators and methods of making and using the sameNOGRA PHARMA LTD·Filed 2024·Granted Mar 17, 2026·0 cites·6 claims
- 3883US10562883B2Heterocycles capable of modulating T-cell responses, and methods of using sameNOGRA PHARMA LTD·Filed 2018·Granted Feb 18, 2020·5 cites·14 claims
- 3982US11905232B2Process of making 3-(4′-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereofNOGRA PHARMA LTD·Filed 2020·Granted Feb 20, 2024·2 cites·19 claims
- 4081US10208017B2Heterocycles capable of modulating T-cell responses, and methods of using sameNOGRA PHARMA LTD·Filed 2013·Granted Feb 19, 2019·7 cites·10 claims
- 4180US2022354809A1Alkylamido Compounds and Uses ThereofNOGRA PHARMA LTD·Filed 2021·Application pending·0 cites
- 4279US12509416B2Process of making 3-(4′-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereofNOGRA PHARMA LTD·Filed 2024·Granted Dec 30, 2025·0 cites·20 claims
- 4378US2015148418A1Methods of Treating Hair Related ConditionsNOGRA PHARMA LTD·Filed 2014·Application pending·0 cites
- 4477US2020325480A1Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical FieldNOGRA PHARMA LTD·Filed 2020·Application pending·0 cites
- 4576US2024368604A1Il-34 antisense agents and methods of using sameNOGRA PHARMA LTD·Filed 2024·Application pending·0 cites
- 4676US2021290656A1Antisense Compositions and Methods of Making and Using SameNOGRA PHARMA LTD·Filed 2021·Application pending·0 cites
- 4775US2019269637A1Alkylamido Compounds and Uses ThereofNOGRA PHARMA LTD·Filed 2018·Application pending·0 cites
- 4874US2020383942A1Alkylamido Compounds and Uses ThereofNOGRA PHARMA LTD·Filed 2020·Application pending·0 cites
- 4972US12071623B2IL-34 antisense agents and methods of using sameNOGRA PHARMA LTD·Filed 2022·Granted Aug 27, 2024·0 cites·11 claims
- 5071US11427600B2Aryl receptor modulators and methods of making and using the sameNOGRA PHARMA LTD·Filed 2015·Granted Aug 30, 2022·1 cites·3 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →